Abstract
Epidermal growth factor receptor (EGFR) protein tyrosine kinases (PTKs) are known for its role in cancer. QSAR studies were performed on a set of 137 analogs of quinazoline using MDS vlife science QSAR plus module by using Multiple Linear Regression (MLR), Principal Component Regression (PCR) and Partial Least Squares (PLS) Regression methods. Among these, MLR method has shown a very promising result as compared to other two methods and a QSAR model was generated by a training set of 100 molecules with correlation coefficient (r2) of 0.884, significant cross validated correlation coefficient (q2) of 0.800, F test of 39.5149, r2 for external test set (pred_r2) 0.5902, coefficient of correlation of predicted data set (pred_r2se) 0.7438 and degree of freedom 83. In the selected descriptors, alignment independent descriptors T_2_C_5 (11.74%) and T_2_O_7 (-11.27%) are the most important descriptors in predicting EGFR inhibitory activity. Electron withdrawing group at anilino quinazolines enhances the activity as evident by positive value of T_F_Cl_4 (2.07%). In addition, for quinazoline substituents, estate contribution descriptors, SaaCHE – index and Ssss NE-index have a large deactivating effect.
Keywords: Quinazoline, Tyrosine kinase (EGFR), Multiple Linear Regression (MLR), Principal Component Regression (PCR), Partial Least Squares (PLS)
Letters in Drug Design & Discovery
Title: 2D QSAR Studies on a Series of Quinazoline Derivatives as Tyrosine Kinase (EGFR) Inhibitor: An Approach to Design Anticancer Agents
Volume: 7 Issue: 8
Author(s): Malleshappa N. Noolvi and Harun M. Patel
Affiliation:
Keywords: Quinazoline, Tyrosine kinase (EGFR), Multiple Linear Regression (MLR), Principal Component Regression (PCR), Partial Least Squares (PLS)
Abstract: Epidermal growth factor receptor (EGFR) protein tyrosine kinases (PTKs) are known for its role in cancer. QSAR studies were performed on a set of 137 analogs of quinazoline using MDS vlife science QSAR plus module by using Multiple Linear Regression (MLR), Principal Component Regression (PCR) and Partial Least Squares (PLS) Regression methods. Among these, MLR method has shown a very promising result as compared to other two methods and a QSAR model was generated by a training set of 100 molecules with correlation coefficient (r2) of 0.884, significant cross validated correlation coefficient (q2) of 0.800, F test of 39.5149, r2 for external test set (pred_r2) 0.5902, coefficient of correlation of predicted data set (pred_r2se) 0.7438 and degree of freedom 83. In the selected descriptors, alignment independent descriptors T_2_C_5 (11.74%) and T_2_O_7 (-11.27%) are the most important descriptors in predicting EGFR inhibitory activity. Electron withdrawing group at anilino quinazolines enhances the activity as evident by positive value of T_F_Cl_4 (2.07%). In addition, for quinazoline substituents, estate contribution descriptors, SaaCHE – index and Ssss NE-index have a large deactivating effect.
Export Options
About this article
Cite this article as:
N. Noolvi Malleshappa and M. Patel Harun, 2D QSAR Studies on a Series of Quinazoline Derivatives as Tyrosine Kinase (EGFR) Inhibitor: An Approach to Design Anticancer Agents, Letters in Drug Design & Discovery 2010; 7 (8) . https://dx.doi.org/10.2174/157018010792062821
DOI https://dx.doi.org/10.2174/157018010792062821 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antidepressant-Like Components of Hypericum perforatum Extracts: An Overview of Their Pharmacokinetics and Metabolism
Current Drug Metabolism Expression Microarray Proteomics and the Search for Cancer Biomarkers
Current Genomics High-throughput Screening Identifies Small Molecule Inhibitors of Molecular Chaperones
Current Pharmaceutical Design Tyrosinase Electrochemical Biosensors Monitoring Medicinally Significant Substances
Current Medicinal Chemistry Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates
Current Drug Metabolism Synthesis and Cytotoxic Activities of a Curcumin Analogue and Its bis- Mannich Derivatives
Letters in Drug Design & Discovery Fabrication of Multi-functionalized Gold Nanoparticles and the Application to Electrochemical Detection of Nitrite
Current Nanoscience Emerging Toxicity Aspects of Silver Nanoparticles: An Overview
Current Nanomaterials Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Current Medicinal Chemistry Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Buprenorphine and Buprenorphine/Naloxone Intoxication in Children – How Strong is the Risk?
Current Drug Abuse Reviews Antioxidant and ‘Natural Protective’ Properties of Kiwifruit
Current Topics in Medicinal Chemistry Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Current Pharmaceutical Design Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North India
Current HIV Research Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry TNF-α Inhibitors with Anti-Oxidative Stress Activity from Natural Products
Current Topics in Medicinal Chemistry Electrochemical Detection of Polyphenolic Compounds in Foods and Beverages
Current Analytical Chemistry Killer Beacons for Combined Cancer Imaging and Therapy
Current Medicinal Chemistry Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology